Experts in the field discuss new therapies and how they will impact the dermatologist's practice.

Nada Elbuluk, MD, FAAD: Research and Utility of Ruxolitinib Cream for Vitiligo

Dr. Elbuluk discusses results of the clinical trials for ruxolitinib cream in patients with vitiligo and how this treatment is being incorporated into the dermatologist’s vitiligo toolkit.


Dr. Elbuluk discusses a recently published retrospective chart review that she and her colleagues published in the Archives of Dermatological Research, which included all patients diagnosed with vitiligo treated at a private hospital and a public hospital over a period of ten years, with a focus on associated psychiatric comorbidities. She summarizes the findings of rates of anxiety and depression in patients with vitiligo in terms of gender, race, and socioeconomic status....
Seemal Desai, MD, a board-certified dermatologist in private and academic practice in Dallas, Texas, discusses the positive impact a recent topical approval has shown for the treatment of vitiligo. He mentions the current effectiveness of excimer lasers for phototherapy as well as potential new surgical procedures on the horizon in 2023....